AtriCure, Inc. 8-K

What Happened
AtriCure, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025 in a press release dated February 17, 2026, and filed an 8-K (Item 2.02) to disclose the results. The company scheduled a conference call for February 17, 2026 at 4:30 p.m. Eastern Time to discuss the results and take questions from investors and analysts.

Key Details

• Press release/report date: February 17, 2026 (filed as Exhibit 99.1 to the Form 8-K).
• Period covered: Fourth quarter and full year ended December 31, 2025.
• Conference call: February 17, 2026 at 4:30 p.m. Eastern Time to review results.
• Form 8-K signed by Angela L. Wirick, Chief Financial Officer; Inline XBRL cover page included.

Why It Matters
This 8-K signals that AtriCure is publicly disclosing its latest earnings and financial condition for Q4 and FY 2025, which can affect investor decisions and the company’s stock price. The scheduled conference call gives investors a chance to hear management’s commentary and ask questions about revenue, profitability, guidance, or other material items disclosed in the press release. Investors should review the press release/Exhibit 99.1 and listen to the call for the detailed financial figures and management outlook.